- Home
- NCPL vs RSLS Comparison
NCPL vs RSLS Comparison
Compare NCPL & RSLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCPL
- RSLS
- Stock Information
- Founded
- NCPL 1984
- RSLS 2002
- Country
- NCPL United States
- RSLS United States
- Employees
- NCPL N/A
- RSLS N/A
- Industry
- NCPL Investment Managers
- RSLS Medical/Dental Instruments
- Sector
- NCPL Finance
- RSLS Health Care
- Exchange
- NCPL Nasdaq
- RSLS Nasdaq
- Market Cap
- NCPL 4.3M
- RSLS 4.5M
- IPO Year
- NCPL N/A
- RSLS 2007
- Fundamental
- Price
- NCPL $6.58
- RSLS $2.50
- Analyst Decision
- NCPL
- RSLS Hold
- Analyst Count
- NCPL 0
- RSLS 1
- Target Price
- NCPL N/A
- RSLS N/A
- AVG Volume (30 Days)
- NCPL 850.8K
- RSLS 4.4M
- Earning Date
- NCPL 07-28-2025
- RSLS 08-13-2025
- Dividend Yield
- NCPL N/A
- RSLS N/A
- EPS Growth
- NCPL N/A
- RSLS N/A
- EPS
- NCPL N/A
- RSLS N/A
- Revenue
- NCPL $812,612.00
- RSLS $7,175,000.00
- Revenue This Year
- NCPL N/A
- RSLS $52.80
- Revenue Next Year
- NCPL $101.16
- RSLS N/A
- P/E Ratio
- NCPL N/A
- RSLS N/A
- Revenue Growth
- NCPL N/A
- RSLS N/A
- 52 Week Low
- NCPL $1.41
- RSLS $2.23
- 52 Week High
- NCPL $11.90
- RSLS $414.99
- Technical
- Relative Strength Index (RSI)
- NCPL 63.58
- RSLS 38.69
- Support Level
- NCPL $5.70
- RSLS $2.37
- Resistance Level
- NCPL $7.31
- RSLS $2.73
- Average True Range (ATR)
- NCPL 1.16
- RSLS 0.19
- MACD
- NCPL 0.13
- RSLS 0.22
- Stochastic Oscillator
- NCPL 62.27
- RSLS 22.22
About NCPL Netcapital Inc.
Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus. Geographically, the company operates in the United States, Australia, Europe, and the Rest of world, and the majority of its revenue is generated from the United States.